Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02270892 · ClinicalTrials.gov registry record · NA
Ultherapy for Buttock Lift
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT02270892 is a NA study that has completed, run by Ulthera. The registered enrollment target is 38 participants.
The verdict
NCT02270892, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Up to 24 subjects will be enrolled and treated. Enrolled subjects will receive two Ulthera® treatments, 90 days apart. Follow-up visits will occur at 90, 180, and 270 days following the last treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
Interventions
- DEVICE Ulthera treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2014-08-28 |
| Est. Completion | 2017-04-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02270892
The ClinicalTrials.gov registry entry for NCT02270892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ulthera treatment is the first listed.
NCT02270892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02270892 about?
NCT02270892 is a clinical study titled "Ultherapy for Buttock Lift". Up to 24 subjects will be enrolled and treated. Enrolled subjects will receive two Ulthera® treatments, 90 days apart. Follow-up visits will occur at 90, 180, and 270 days following the last treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up vis...
What is the current status of trial NCT02270892?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2014-08-28. Estimated completion is 2017-04-03.
What interventions are being tested in trial NCT02270892?
The interventions under investigation include: Ulthera treatment (DEVICE).
Who is sponsoring clinical trial NCT02270892?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.